000			02062 a2200589 4500
005			20250516181005.0
264		0	_c20140522
008			201405s 0 0 eng d
022			_a1097-0215
024	7		_a10.1002/ijc.28597 _2doi
040			_aNLM _beng _cNLM
100	1		_aRaykov, Zahary
245	0	0	_aMyo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. _h[electronic resource]
260			_bInternational journal of cancer _cJun 2014
300			_a2572-82 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDrug Synergism
650	0	4	_aFluorescent Antibody Technique
650	0	4	_aHumans
650	0	4	_aHypoxia _xdrug therapy
650	0	4	_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors
650	0	4	_aInositol Phosphates _xtherapeutic use
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aNeovascularization, Pathologic
650	0	4	_aOxygen _xmetabolism
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRats
650	0	4	_aRats, Inbred Lew
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTumor Cells, Cultured
650	0	4	_aGemcitabine
700	1		_aGrekova, Svitlana P
700	1		_aBour, Gaétan
700	1		_aLehn, Jean Marie
700	1		_aGiese, N A
700	1		_aNicolau, Claude
700	1		_aAprahamian, Marc
773	0		_tInternational journal of cancer _gvol. 134 _gno. 11 _gp. 2572-82
856	4	0	_uhttps://doi.org/10.1002/ijc.28597 _zAvailable from publisher's website
999			_c23251051 _d23251051